{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260624388810/en/Kadima-Neuropsychiatry-Institute-Files-Suit-Against-NRx-Pharmaceuticals-NASDAQ-NRXP-Alleging-Breach-of-Contract-and-Misrepresentation-in-Connection-with-Acquisition", "message": "News view counter 814608 successfully enlarged"}